1. Home
  2. LFCR

LFCR

Lifecore Biomedical Inc.

Logo Lifecore Biomedical Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-23-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, filling, and finishing of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Lifecore recognizes revenue in two different product categories, CDMO and fermentation.

Founded: 1986 Country:
N/A
Employees: N/A City: CHASKA
Market Cap: 204.4M IPO Year: N/A
Target Price: $9.50 AVG Volume (30 days): 203.9K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -3.32 EPS Growth: N/A
52 Week Low/High: $3.69 - $11.46 Next Earning Date: 01-01-0001
Revenue: $103,269,000 Revenue Growth: -7.19%
Revenue Growth (this year): 23.86% Revenue Growth (next year): 15.39%

Share on Social Networks: